Swift Biosciences has expertise and intellectual property in sample preparation, library construction, and DNA amplification. These technologies offer application-specific solutions in the field of next-generation sequencing (NGS), as well as quantitative polymerase chain reaction.
With respect to DNA sequencing, Swift Biosciences has core technologies enabling the construction of libraries from difficult-to-use and preciously limiting samples, such as formalin-fixed, paraffin-embedded (FFPE), cell-free DNA (cfDNA), and circulating tumor cells (CTCs). Swift technology enables the construction of libraries that offer the most complex, rich, and diverse data while eliminating noise created by duplicates and adapter-dimers. These library construction technologies used in combination with NGS enable the detection of genetics and epigenetics, as well as somatic variation from a wide variety of samples.
View Swift’s press releases with their partners for DNA sequencing
With respect to targeted DNA sequencing panels, Swift Biosciences is an original design manufacturer (ODM). Swift designs, validates, manufactures, and packages custom targeted sequencing panels for resale and for use in service labs. Swift has the expertise and capability to design and manufacture targeted panels in humans for a multitude of applications such as oncology, cardiology, and human disease research.
View Swift’s press releases with their partners for targeted sequencing panels